According to Algernon Pharmaceuticals latest financial reports the cash on hand of AGN is $91.88K, an decrease of -91.12% to 2022. At the end of 2022 company had $1.03M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $91.88K | -91.12% |
2022 | $1.03M | -41.58% |
2021 | $1.77M | -60.61% |
2020 | $4.50M | 2845.65% |
2019 | $152.64K | -83.39% |
2018 | $918.92K | - |